In today’s hospitals and healthcare clinics, a new doctor’s new assistant is now often on the job — in the form of artificial intelligence. Whether it’s analyzing medical images or guiding robots that assist with surgeries, AI is making steady inroads into our hospitals and clinics. Need an online nursing assistant or a watchdog that helps detect dosage errors? There’s an AI application for that.
The advent of AI in healthcare is a promising trend in terms of both patient care and economic efficiency. AI can help us address a forecasted shortage of physicians, particularly in specialty-care fields, while containing the costs of caring for an aging and growing population. A recent study by a team of researchers from the consulting firm Accenture found that the use of 10 promising AI applications could create up to $150 billion in annual savings for U.S. healthcare by 2026.
For an example of the potential of AI in healthcare, we need to look no further than Gustave Roussy, a leading European center for cancer research and care. In a study published this summer in the medical journal The Lancet Oncology, a team of medical researchers from Gustave Roussy and a few other institutions demonstrated that AI can process medical images to extract biological and clinical information to help with immunotherapy treatment, according to a news release on the study.
In this groundbreaking study, the researchers used an algorithm they designed and developed to analyze CT scan images and create a “radiomic signature.” This signature defines the level of lymphocyte infiltration of a tumor — or the degree to which immune cells have moved from the blood into a tumor cell. The radiomic signature also provides a predictive score for the efficacy of immunotherapy in the patient.
Here’s how AI played into this research: Using an approach based on machine learning, the team first taught the algorithm to use relevant information extracted from CT scans of patients participating in the study. Then, based solely on images, the algorithm learned to predict what the genome might have revealed about the tumor immune infiltrate, and it established the radiomic signature.
The announcement summarizing the findings of the study notes that in the future, physicians might be able to use imaging to identify biological phenomena in a tumor located in any part of the body without having to perform a biopsy.
At Dell EMC, this research is particularly close to our hearts because we are active supporters of Gustave Roussy.
Image Credit: Dell EMC
News This Week
Immune Aspects of Biopharmaceuticals and Nanomedicines 1st Edition Raj Bawa, Janos Szebeni, Thomas J Webster, Gerald F. Audette The enormous advances in the immunology of biotherapeutics and nanomedicines in the past two decades have [...]
LAS CRUCES, N.M. — Members of an independent NASA safety panel said they were worried that the Oct. 11 Soyuz launch failure could make safety concerns with the agency's commercial crew program even worse. [...]
Canadian astronaut Col. Chris Hadfield (Ret.) on Friday said that human travel to space will happen sooner than we think, adding that the first destination will likely be a return trip to the moon. [...]
Antibody-based imaging of a particularly aggressive form of breast cancer is undergoing clinical trials worldwide, but the path from trial to application is being hampered by a major obstacle: safety. Concerns stem from inefficient [...]
Following the discovery of graphene in 2003, there has been considerable interest in other types of 2D materials. However, splitting a bulk crystal material into 2D flakes for use in electronics has proven hard [...]
The digital economy is set to unlock tremendous economic value for countries over time. But a common setback for the use of various new technologies is their vulnerability to hackers. That's because companies and [...]
Nanomedical Device and Systems Design: Challenges, Possibilities, Visions now available to rent on Kindle
To accommodate students who wish to read the book at an affordable cost, Nanomedical Device and Systems Design: Challenges, Possibilities, Visions by Frank Boehm (CEO NanoApps Medical Inc.) is available to rent on Kindle. This book benefits [...]
The last five years has seen a surge of attacks on the healthcare industry, with the largest breaches impacting as many as 80 million people. In July this year, it was revealed that 150,000 [...]
The Nanoaugmented Materials Industry Summit (NAUM) 2018 in Shanghai on October 31 will gather the world’s leading companies who use and apply graphene nanotubes to share exciting results. This year the event is opening [...]
Any truck operator knows that hydraulics do the heavy lifting. Water does the work because it's nearly incompressible at normal scales. But things behave strangely in nanotechnology, the control of materials at the scale [...]
Myeloperoxidase - an enzyme naturally found in our lungs - can biodegrade pristine graphene, according to the latest discovery of Graphene Flagship partners in CNRS, University of Strasbourg (France), Karolinska Institute (Sweden) and University [...]
In today’s hospitals and healthcare clinics, a new doctor’s new assistant is now often on the job — in the form of artificial intelligence. Whether it’s analyzing medical images or guiding robots that assist [...]
Healthcare cybersecurity will be one of the top 10 challenges, issues, and/or opportunities facing healthcare executives next year, according to a new poll by the Healthcare Executive Group (HCEG). Healthcare cybersecurity covers such issues [...]
A research team has developed a nano-platform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma. Drug resistance to chemotherapy is a significant clinical and financial [...]